by Ted Rogers Centre for Heart Research | May 11, 2021 | Education & Training, Equitable Access to Care, Investigating Heart Failure, Personalized Medicine, Why Heart Failure
TRANSFORM HF: digital innovation for heart failure care
by Ted Rogers Centre for Heart Research | Feb 22, 2021 | Equitable Access to Care, Investigating Heart Failure, Personalized Medicine, Translating Innovation
Studying how Apple Watch can keep HF patients safe
by Ted Rogers Centre for Heart Research | Feb 11, 2021 | Personalized Medicine, Why Heart Failure
Remarkable family history leads to chance to save lives
by Ted Rogers Centre for Heart Research | Feb 3, 2021 | Equitable Access to Care, Investigating Heart Failure, Personalized Medicine, Translating Innovation
Measuring strain key to detecting CV damage by chemotherapy
by Ted Rogers Centre for Heart Research | Jan 6, 2021 | Investigating Heart Failure, Personalized Medicine
Statins found to help protect hearts of breast cancer patients
by Ted Rogers Centre for Heart Research | Nov 30, 2020 | Investigating Heart Failure, Personalized Medicine
On a new diabetes drug that reduces the risk of heart failure
by Ted Rogers Centre for Heart Research | Sep 16, 2020 | Equitable Access to Care, Personalized Medicine, Translating Innovation
“It’s a tremendous opportunity”
by Ted Rogers Centre for Heart Research | Sep 1, 2020 | Education & Training, Equitable Access to Care, Investigating Heart Failure, Personalized Medicine
Blockbuster presentation at ESC 2020
by Ted Rogers Centre for Heart Research | Jun 17, 2020 | Equitable Access to Care, Funding Opportunities, Investigating Heart Failure, Personalized Medicine
The first sign of Brugada syndrome is often sudden death
by Ted Rogers Centre for Heart Research | May 24, 2020 | Equitable Access to Care, Personalized Medicine
We must tailor research and care accordingly